PROPHYLAXIS OF PNEUMOCOCCAL INFECTION WITH VACCINES FOR PREVENTION OF COMPLICATIONS AND DEATH IN PATIENTS WITH INFLUENZA
Abstract
Key words: children, pneumococcal infection, influenza, complications, mortality, vaccination.
(Voprosy sovremennoi pediatrii — Current Pediatrics. 2010;9(6):131-134)
About the Authors
M.P. KostinovRussian Federation
D.V. Pakhomov
Russian Federation
O.O. Magarshak
Russian Federation
References
1. Neuzil K.M., Mellen B.G., Wright P.F. et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotic in children. N. Engl. J. Med. 2000; 342: 225–231.
2. Smil V. The next 50 years: fatal discontinuities. Pop. Dev. Rev. 2005; 1: 201–236.
3. Henig R.M. The emergence of a new flu. In: A Dancing Matrix; Voyages Along the Viral Frontier. New York: Alfred A. Knopf. 1993.
4. Centers for Disease Control and Prevention (CDC). Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) United States, May-August 2009. MMWR Morb Mortal Wkly Rep. 2009; 58(38): 1071–1074.
5. Hansen J., Black S., Shinefield H. et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumoniae: updated analysis using World Health Organization standardized interpretation of chest radiation. Pediatr. Infect. Dis. J. 2006; 25: 779–781.
6. Cherian T., Mulholland E.K., Carlin J.B. et al. WHO Radiology Working Group Standardized interpretation of paediatric chest radiographs for the diagnostics of pneumonia in epidemiological studies. Bull. World. Health. Organ. 2005; 83: 353–359.
7. Klugman K.P., Madhi S.A., Huebner R.E. et al. Vaccine Trialists Group. A trial of 9-valent pneumococcal conjugate vaccine in children with and those without HIV–infection. N. Engl. J. Med. 2003; 349: 1341–1348.
8. Cutts F.T., Zaman S.M., Enwere G. et al. Gambial Pneumococcal Vaccine Trial Group. Eficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in Gambia: randomized, double blind, placebo controlled trial. Lancet. 2005; 365: 1139–1146.
9. Zhou F., Kyaw M.N., Shefer A. et al. Health care utilization for pneumoniae in young children after routine pneumococcal conjugate vaccine use in the United States. Arch. Pediatr. Adolesc. Med. 2007; 161: 1162–1168.
10. Grijalva C.G., Nuorti J.P., Arbogast P.G. et al. Decline in pneumoniae admissions after routine childhood immunization with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet. 2007; 369: 1179–1186.
11. Brimblecombe F.S., Cruickshank R., Masters P.L. et al. Family studies of respiratory infections. BMJ. 1958. P. 119–128.
12. Morens D.M., Taubenberger J.K., Fauci A.S. Predominant role of bacterial pneumoniae as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infect. Dis. 2008; 198: 962–970.
13. Fiore A.E., Shay D.K., Broder K. et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm. Rep. 2009; 58 (RR-8): 1–52.
14. McCullers J.A. Insights into interaction between influenza virus and pneumococcus. Clin. Microbiol. Rev. 2006; 19: 571–582.
15. O’Brien K.L., Walters M.L., Sellman J. et al. Severe pneumococcal pneumoniae in previously healthy children: the role of preceding influenza infection. Clin. Infect. Dis. 2000; 30: 784–789.
16. Smillie W.G., Warnock G.H., White H.J. A study of a type I pneumococcus epidemic at the state hospital of Worcester, MA. Am. J. Public. Health. 1938; 28: 293–302.
17. Stensballe L.G., Hjuller T., Andersen A. et al. Hospitalization for respiratory syncytial virus infrction and invasive pneumococcal disease: in Danish children aged <2 years: a population based cohort study. Clin. Infect. Dis. 2008; 46: 1165–1171.
18. Michelow I.C., Olsen K., Lozano J. et al. Epidemiology and clinical characteristics of community-acquired pneumoniae in hospitalized children. Pediatrics. 2004; 113: 701–707.
19. Madhi S.A., Klugman K.P. Vaccine trialist group. A role for Streptococcus pneumonia in virus associated pneumonia. Nat. Med. 2004; 10: 811–813.
Review
For citations:
Kostinov M., Pakhomov D., Magarshak O. PROPHYLAXIS OF PNEUMOCOCCAL INFECTION WITH VACCINES FOR PREVENTION OF COMPLICATIONS AND DEATH IN PATIENTS WITH INFLUENZA. Current Pediatrics. 2010;9(6):131-134.
Email this article 
